Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy

Authors :: Marco Guglielmo
Andrea Annoni
Rocco Mollace
Maria Elisabetta Mancini
Giuseppe Muscogiuri
Edoardo Conte
Saima Mushtaq
Elena Sommariva
Claudio Tondo
Andrea Baggiano
Mario Babbaro
Cristina Basso
Ada Collevecchio
Mark G. Rabbat
Alessio Gasperetti
Deni Kukavica
Alberto Formenti
Antonio Dello Russo
Stefania Rizzo
Daniele Andreini
Mauro Pepi
Michela Casella
Monica De Gaspari
Francesca Ricci
Stefano Scafuri
Silvia G. Priori
Andrea Igoren Guaricci
Rita Sicuso
Gianluca Pontone
Laura Fusini
Muscogiuri, G
Fusini, L
Ricci, F
Sicuso, R
Guglielmo, M
Baggiano, A
Gasperetti, A
Casella, M
Mushtaq, S
Conte, E
Annoni, A
Formenti, A
Mancini, M
Babbaro, M
Mollace, R
Collevecchio, A
Scafuri, S
Kukavica, D
Andreini, D
Basso, C
Rizzo, S
De Gaspari, M
Priori, S
Dello Russo, A
Tondo, C
Pepi, M
Sommariva, E
Rabbat, M
Guaricci, A
Pontone, G
Publication Year :: 2021
Publisher :: Elsevier Ireland Ltd, 2021.
Abstract: Background: We aim to evaluate the value of Cardiac magnetic resonance (CMR) feature tracking (CMR-FT) in addition to Task Force Criteria(TFC) in patients with (arrhythmogenic cardiomyopathy) AC biopsy-proved. Methods: Thirty-five patients with AC histologically proven who performed CMR with late gadolinium enhancement (LGE) acquisition were enrolled. The study population was divided in Group1 (negative CMR TFC and LV ejection fraction≥55%) and Group2 (positive CMR TFC and/or LVEF

Tools